TAK

Quote

Short

News

Articles

Message Board

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) (NYSE : TAK ) News

News Releases

TAK News Releases

July 16, 2026 06:00:00 pm

Business Wire

Takeda's Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies

July 08, 2026 02:46:06 pm

SeekingAlpha

A New Look At Legend Biotech: Plenty Of Upside For Carvykti

July 02, 2026 09:44:33 am

SeekingAlpha

Ascendis Pharma: Behind The Stock Surge

July 02, 2026 07:01:21 am

SeekingAlpha

Takeda, Insilico sign AI drug discovery pact worth up to $600M

June 26, 2026 09:22:31 am

SeekingAlpha

Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)

June 24, 2026 03:51:01 am

SeekingAlpha

Takeda finalizes 18-month transition: Julie Kim officially appointed President & CEO

June 24, 2026 03:05:00 am

Business Wire

Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO

June 23, 2026 08:00:00 am

Canada Newswire

Takeda's Zasocitinib Achieved Significantly Greater Complete Skin Clearance Than Deucravacitinib in Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

June 15, 2026 12:00:00 pm

Business Wire

New Pivotal Study Data Show Takeda's Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1

June 11, 2026 03:27:41 pm

SeekingAlpha

Takeda Pharmaceutical: The Downside Was Forecastable

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account